获取途径

作者

Liaoran Niu Xiaoyu Kang Jianyong Zheng Fei Wu Shushang Liu Liu Hong Haiming Liu Jiuping Wang Daiming Fan Yongzhan Nie Zhangqian Chen

作者单位

⁶Department of Infectious Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China ⁵School of Software Engineering, Beijing Jiaotong University, Beijing, PR China ⁴Department of Urology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong, PR China ³The authors have contributed equally to this work ¹State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, Shaanxi, PR China ²Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, Shaanxi, PR China

刊名

Pharmacological Research

年份

2025

卷号

Vol.221

页码

107996

ISSN

1043-6618

关键词

MicroRNA Epigenetic mechanisms Chemotherapy resistance Oxidative phosphorylation Gastric cancer

摘要

Gastric cancer remains a formidable global health challenge, with drug resistance being a primary contributor to its high mortality rates. Therefore, understanding the mechanisms driving drug resistance is crucial for developing more effective therapeutic interventions. Utilizing high content screening technology, we identified let-7e-5p and miR-125a-5p as the key regulators of drug resistance in GC, both being members of the miR-99b cluster. Findings from GC cells, organoids and PDX models demo...更多

Gastric cancer remains a formidable global health challenge, with drug resistance being a primary contributor to its high mortality rates. Therefore, understanding the mechanisms driving drug resistance is crucial for developing more effective therapeutic interventions. Utilizing high content screening technology, we identified let-7e-5p and miR-125a-5p as the key regulators of drug resistance in GC, both being members of the miR-99b cluster. Findings from GC cells, organoids and PDX models demonstrated that overexpression of the miR-99b cluster sensitized GC to cisplatin, likely through its inhibitory effects on mitochondrial respiratory function, particularly OXPHOS. We further demonstrated that multiple components, especially SDHC subunit of respiratory complex II, were regulated by miR-99b cluster and played critical roles in GC chemoresistance. Then, through a comprehensive screen of epigenetic compounds, we identified KMT5A as a key upstream repressor of the miR-99b cluster in GC, which reinforces the H4K20me1 modification within the miR-99b cluster region. Moreover, elevated KMT5A expression and decreased miR-125a-5p expression indicated both poorer prognosis and chemo-resistance in patients with GC. This study highlights the multifaceted roles of the miR-99b cluster in GC and offers novel perspectives for the development of innovative therapeutics aimed at overcoming chemoresistance and enhancing treatment efficacy for GC patients.收起

文献类型

期刊